AtriCure, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
AtriCure, Inc. (ATRC) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $4.32 million as of 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-07-27
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $4.32M.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $4.58M.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $4.84M.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $5.10M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $4.32M 10-Q · filed 2026-07-27 |
| 2026-03-31 | $4.58M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $4.84M 10-Q · filed 2026-07-27 |
| 2025-09-30 | $5.10M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $5.37M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $5.63M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $5.89M 10-K · filed 2026-02-19 |
| 2024-09-30 | $6.15M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $6.41M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $6.26M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $6.51M 10-K · filed 2025-02-14 |
| 2023-09-30 | $6.77M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $7.28M 10-Q · filed 2023-07-26 |
| 2023-03-31 | $7.28M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $7.54M 10-K · filed 2024-02-16 |
| 2021-12-31 | $8.49M 10-K · filed 2023-02-22 |
| 2020-12-31 | $9.41M 10-K · filed 2022-02-17 |
| 2019-12-31 | $10.54M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |